Z
Z

ZurichInsurance

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Five things to know about Credit Suisse's new chairman Lehmann

Jan 17 (Reuters) - Credit Suisse's CSGN.S chairman Antonio Horta-Osorio resigned on Monday following an investigation by the Swiss bank's board into his personal conduct. He will be replaced by Axel Lehmann, who joined the Credit Suisse board in October to head its risk committee following a series of scandals. Here are five facts about Lehmann. CR
C
U
Z

Credit Suisse faces more upheaval after chairman's sudden exit

* Chairman Antonio Horta-Osorio apologises for personal actions * Quits within one year after taking charge * Bank appoints former UBS executive Axel Lehmann as chairman * Lehmann says bank's strategy is not under discussion * Credit Suisse announced big revamp in November By Anshuman Daga and Oliver Hirt SINGAPORE/ZURICH, Jan 17 (Reuters) - Credit
C
L
U
Z

Gloomy outlook for global recovery, World Economic Forum survey finds

By Carolyn Cohn LONDON, Jan 11 (Reuters) - Only one in 10 World Economic Forum members surveyed expects the global recovery to accelerate over the next three years, a poll of nearly 1,000 business, government and academic leaders found, with only one in six optimistic about the world outlook. Climate change was seen as the number one danger by resp
Z

Zurich Insurance Group Announces Placement Of Subordinated Debt

Jan 7 (Reuters) - Zurich Insurance Group AG ZURN.S : * ZURICH ANNOUNCES SUCCESSFUL PLACEMENT OF CHF 275 MILLION OF SUBORDINATED DEBT * NOTES, WHICH WILL MATURE IN MAY 2052 AND ARE FIRST CALLABLE IN FEBRUARY 2032, WILL BE ISSUED BY ZURICH INSURANCE COMPANY LTD * ANNUAL COUPON IS FIXED AT 1.5% UNTIL MAY 2032. Further company coverage: ZURN.S
Z

Zurich Insurance to sell Italian life and pensions back book to GamaLife

ZURICH, Jan 3 (Reuters) - Zurich Insurance ZURN.S will release about $1.2 billion of capital by selling its Italian life and pensions back book to Portuguese insurer GamaLife, the Swiss company said on Monday. The deal will also add 11 percentage points to its Swiss Solvency Test ratio and reduce credit risk exposure significantly, Zurich said. The
Z

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.